Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 7,379 shares at $11.14 ($82K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Seasonal sale ($82k) by General Counsel — this insider has traded URGN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 1,258 | $14K | 17.0% |
| 2 | $11.14 | 2,767 | $31K | 37.5% |
| 3 | $11.14 | 3,354 | $37K | 45.5% |
| Total | $11.14 avg | 7,379 | $82K | 100% |
| Filing → |
| URGN | SELL | 2025-09-09 | $29K | — | Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2024-09-12 | $20K | — | Filing → |